Search Results1-16 of  16

  • SERIU TAKU ID: 9000255932332

    The Third Department of Internal Medicine, Kyoto Prefectural University of Medicine (1993 from CiNii)

    Articles in CiNii:1

    • A COMBINED SULBACTAM/CEFOPERAZONE AND AMIKACIN THERAPY FOR THE TREATMENT OF INFECTIONS COMPLICATED WITH HEMATOLOGICAL DESEASES (1993)
  • SERIU TAKU ID: 9000255932495

    The Third Department of Meidicine, Kyoto Prefectural University of Medicine (1993 from CiNii)

    Articles in CiNii:1

    • CLINICAL EFFECTS OF A COMBINATION TREATMENT WITH CEFODIZIME AND MINOCYCLINE FOR INFECTIONS IN PATIENTS COMPLICATED WITH HEMATOLOGICAL DISORDERS (1993)
  • SERIU TAKU ID: 9000256790830

    The Third Department of Internal Medicine, Kyoto Prefectural University of Medicine (1991 from CiNii)

    Articles in CiNii:1

    • CLINICAL EVALUATION OF A COMBINATION TREATMENT WITH CEFMINOX AND FOSFOMYCIN FOR INFECTIONS COMPLICATED IN PATIENTS WITH HEMATOLOGICAL DISORDERS (1991)
  • SERIU TAKU ID: 9000256792393

    The Third Department of Internal Medicine, Kyoto Prefectural University of Medicine (1992 from CiNii)

    Articles in CiNii:1

    • CLINICAL EVALUATION OF CEFTAZIDIME MONOTHERAPY FOR INFECTIONS COMPLICATED WITH HEMATOLOGICAL DISORDERS (1992)
  • SERIU TAKU ID: 9000256793455

    The Third Department of Internal Medicine, Kyoto Prefectural University of Medicine (1993 from CiNii)

    Articles in CiNii:1

    • CLINICAL EVALUATION OF IMIPENEM/CILASTATIN SODIUM AND FOSFOMYCIN AS SECOND-LINE COMBINATION CHEMOTHERAPY IN SEVERE INFECTIONS ASSOCIATED WITH HEMATOLOGIC DISORDERS (1993)
  • SERIU TAKU ID: 9000256795080

    The Third Department of Internal Medicine, Kyoto Prefectural University of Medicine (1994 from CiNii)

    Articles in CiNii:1

    • CLINICAL EFFECTS OF A COMBINATION TREATMENT WITH FOSFOMYCIN AND CLAVULANIC ACID/TICARCILLIN FOR INFECTIONS IN PATIENTS COMPLICATED WITH HEMATOLOGICAL DISORDERS (1994)
  • SERIU Taku ID: 9000000502032

    Third Department of Internal Medicine and Department of Hygiene, Kyoto Prefectural University of Medicine (1998 from CiNii)

    Articles in CiNii:1

    • Mutational analysis of the N-ras gene in acute lymphoblastic leukemia: a study of 125 Japanese pediatric cases (1998)
  • SERIU Taku ID: 9000001707285

    Nuclear Medicine, Gunma University Hospital (2005 from CiNii)

    Articles in CiNii:1

    • Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate (^<90>Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma (2005)
  • SERIU Taku ID: 9000005834432

    Articles in CiNii:20

    • Dose Investigation of Superparamagnetic Iron Oxide (SPIO) SH U 555 A in Liver MR Imaging (2003)
    • Drug development in Japan : from the viewpoints of global pharmaceutical companies (2009)
    • Pharmacological properties and clinical efficacy of dasatinib hydrate (Sprycel^【○!R】), an anticancer drug for chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia (2009)
  • SERIU Taku ID: 9000011174560

    Institute of Human Genetics, University of Heidelberg (2003 from CiNii)

    Articles in CiNii:1

    • Size and Composition of T-Cell Receptor δ (TCRS) Junctional Sequences Are Not Predictive of the Sensitivity of Clonospecific Oligonucleotides Designed for Detection of Minimal Residual Disease in Acute Lymphoblastic Leukemia (2003)
  • SERIU Taku ID: 9000019093518

    R&D Japan, Bristol-Myers K. K. (2012 from CiNii)

    Articles in CiNii:1

    • Markov Chain Monte Carlo Bayesian Analysis for Population Pharmacokinetics of Dasatinib in Japanese Adult Subjects with Chronic Myeloid Leukemia and Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (2012)
  • SERIU Taku ID: 9000255896066

    Third Department of Internal Medicine, Kyoto Prefectural University of Medicine (1992 from CiNii)

    Articles in CiNii:1

    • Detection of Minimal Residual Disease in Leukemic Patients. (1992)
  • SERIU Taku ID: 9000258044220

    ブリストル・マイヤーズ(株)研究開発部門 (2009 from CiNii)

    Articles in CiNii:1

    • Drug development in Japan—from the viewpoints of global pharmaceutical companies (2009)
  • SERIU Taku ID: 9000265257967

    R&D Japan, Bristol-Myers K.K. (2012 from CiNii)

    Articles in CiNii:1

    • Markov Chain Monte Carlo Bayesian Analysis for Population Pharmacokinetics of Dasatinib in Japanese Adult Subjects with Chronic Myeloid Leukemia and Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (2012)
  • Seriu Taku ID: 9000238881392

    Articles in CiNii:1

    • Dose Investigation of Superparamagnetic Iron Oxide(SPIO)SH U 555 A in Liver MR Imaging (2003)
  • Seriu Taku ID: 9000359910129

    大塚製薬株式会社 医薬品事業部 新薬開発本部 (2017 from CiNii)

    Articles in CiNii:1

    • Pharmacological characteristics and clinical outcomes of ponatinib (Iclusig<sup>®</sup>), a third-generation tyrosine kinase inhibitor (2017)
Page Top